- Open Access
Reporting transparency: making the ethical mandate explicit
BMC Medicinevolume 14, Article number: 44 (2016)
Improving the transparency and quality of reporting in biomedical research is considered ethically important; yet, this is often based on practical reasons such as the facilitation of peer review. Surprisingly, there has been little explicit discussion regarding the ethical obligations that underpin reporting guidelines. In this commentary, we suggest a number of ethical drivers for the improved reporting of research. These ethical drivers relate to researcher integrity as well as to the benefits derived from improved reporting such as the fair use of resources, minimizing risk of harms, and maximizing benefits. Despite their undoubted benefit to reporting completeness, questions remain regarding the extent to which reporting guidelines can influence processes beyond publication, including researcher integrity or the uptake of scientific research findings into policy or practice. Thus, we consider investigation on the effects of reporting guidelines an important step in providing evidence of their benefits.
Poor research reporting has been estimated to lead to billions of dollars of waste due to unusable results . Key codes of medical practice, such as the Declaration of Helsinki, state that researchers are accountable for the completeness and accuracy of their reports and that these should adhere to accepted guidelines for ethical reporting . Nevertheless, despite such declarations, there has been little explication as to the principles guiding this ethical obligation. The present commentary addresses why researchers should improve their reporting practices, arguing that the important ethical drivers of these obligations are based on the integrity of individuals as researchers as well as the implications for research use, and concluding that reporting guidelines may help us meet these obligations. However, to date, evidence on the latter is lacking.
Researchers, research integrity, and trustworthiness
From an individual’s integrity perspective, obligations derive from values pertaining to those conducting and reporting research. The onus is placed on individuals being honest in their research, with evidence provided in the form of complete and accurate reporting . Furthermore, the principles of fairness and reciprocity require researchers to contribute to the accumulating pool of scientific knowledge . Appropriate contribution requires the content of publications to be useable. Improved reporting increases the potential for appropriate review and evaluation of research, allowing researchers to meet their obligations by usefully contributing to the collective knowledge upon which they draw.
Improving reporting of research may also allow researchers to fulfil what Carter et al.  called the ‘social license’ of research, which requires researchers to go beyond mere compliance with legal mandates and act in accordance with the expectations of society regarding the conduct of research activities, the implication being that poorly reported research fails to meet the societal expectations required for the maintenance of such a license.
Extrinsic values and implications for research
Obligations regarding reporting also stem from principles external to the integrity of individual researchers and reflect concerns regarding the final use of data and results. These obligations include principles of avoiding harms and promoting benefits, and fair use of resources.
If poor reporting is an impediment to appropriate implementation of research findings, then unwarranted or inappropriate use of research findings may expose patients to unnecessary risk of harm , while a failure to take up potentially beneficial research may lead to individual or population health benefits being missed . This concept is important from a perspective of distributive justice, particularly if the failure to replicate research leads to an unwarranted burden on some members of society . Being able to verify the veracity of the data and analysis will be essential in such circumstances. Moreover, there are opportunity costs to funding research. While clear reporting can facilitate replication and reproduction to validate findings, poorly reported research may precipitate a waste of resources if research funds are spent on unsuccessful attempts at reproduction that could have been circumvented had reporting been more complete. A number of studies have shown the difficulties in reproducing research findings [8, 9], with many citing poor reporting of methods for the inability to reproduce results.
Reporting guidelines and meeting the ethical mandate
Reporting guidelines serve as a tool in supporting best practice in reporting. Indeed, several studies have indicated that the use of checklists improves the completeness of reporting [10–14]. The utility of reporting guidelines lies in clear reporting standards that not only serve as an aid for content in reporting, but may also prompt prospective consideration of pertinent issues during the conception of research .
Developed through a profession- or topic-specific consensus approach, reporting guidelines represent a form of self-regulation, as they become a set of de facto standards or professional norms. Their self-regulatory component reflects on the community’s desire to be seen as open, transparent, and honest – derived from the individual motivators for openness – yet guidelines also serve the external drivers; they are often endorsed, or compliance mandated, by journals . By improving knowledge transfer, reporting guidelines may facilitate trustworthiness in, and accountability of, individuals under what O’Neill refers to as the ‘openness agenda’ and the ‘audit agenda’ . Under the openness agenda, study reports that are compliant with best practice are used as a marker of trustworthiness and reflect the honesty of the author(s) through their willingness to transparently report their research. Under the audit agenda, transparent reporting improves accountability by facilitating inspection of performance with respect to professional standards . More complete reporting – consistent with appropriate reporting guidelines – also assists the conduct of systematic reviews and meta-analyses through the better documentation of elements that would require extraction [18, 19]. Such improved reporting may increase the appropriate uptake of research findings.
We have suggested that there are principled reasons behind the obligations to improve the reporting of research and note that this motivation reflects the integrity of individual researchers as well as the external drivers that pertain to the use of research results.
While reporting guidelines serve as a tool for multiple stakeholders, including researchers, prospective authors, and peer reviewers, questions remain regarding the extent to which they can influence processes beyond publication: to what extent do they influence researcher integrity or the uptake of scientific research findings into policy or practice? Put differently, how do they address the ethical drivers that have stimulated the production of reporting guidelines? Evaluations of reporting guidelines have tended to focus on intermediary outcomes or the extent to which published studies comply with the elements within guidelines. Even then, there has been surprisingly limited work in terms of guideline evaluation . Indeed, the direct beneficiaries of reporting guidelines are generally researchers and those who peer review research .
We believe that the paucity of research on the efficacy and effectiveness of reporting guidelines is due to the complex nature of these interactions. It is difficult to attribute the endpoints, such as use of research in policy, to the way the study was reported. However, we believe that demonstrating the effectiveness of reporting guidelines is an important step in providing evidence of their applied benefits to both research funders and the broader public, as researchers seek to justify their work in an era of increasing financial constraints.
Hence, while improving the quality of reporting stems from important ethical drivers such as researcher integrity and the benefits derived from improved reporting, questions regarding the extent to which reporting guidelines can influence researcher integrity, or the uptake of scientific research findings into policy or practice, remain an important and under-investigated area for future research.
Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–76. doi:10.1016/s0140-6736(13)62228-x.
World Medical Association. WMA Declaration of Helsinki - Ethical principles for medical research involving human subjects. Fortaleza, Brazil: World Medical Association; 2013.
Masic I. Ethical aspects and dilemmas of preparing, writing and publishing of the scientific papers in the biomedical journals. Acta Inform Med. 2012;20(3):141–8. doi:10.5455/aim.2012.20.141-148.
Carter P, Laurie GT, Dixon-Woods M. The social licence for research: why care.data ran into trouble. J Med Ethics. 2015;41(5):404–9. doi:10.1136/medethics-2014-102374.
Needleman I, Moher D, Altman DG, Schulz KF, Moles DR, Worthington H. Improving the clarity and transparency of reporting health research: a shared obligation and responsibility. J Dent Res. 2008;87(10):894–5.
Institute of Medicine. Sharing clinical trial data: Maximizing benefits, minimizing risk. Washington, DC: Institute of Medicine; 2015.
Vayena E, Salathe M, Madoff LC, Brownstein JS. Ethical challenges of big data in public health. PLoS Comput Biol. 2015;11(2), e1003904. doi:10.1371/journal.pcbi.1003904.
Vasilevsky NA, Brush MH, Paddock H, Ponting L, Tripathy SJ, Larocca GM, et al. On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ. 2013;1, e148. doi:10.7717/peerj.148.
Open Science Collaboration. Estimating the reproducibility of psychological science. Science. 2015;349(6251):aac4716. doi:10.1126/science.aac4716.
Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012;11:Mr000030. doi:10.1002/14651858.MR000030.pub2.
Sorensen AA, Wojahn RD, Manske MC, Calfee RP. Using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement to assess reporting of observational trials in hand surgery. J Hand Surg Am. 2013;38(8):1584–9. doi:10.1016/j.jhsa.2013.05.008. e2.
Armstrong R, Waters E, Moore L, Riggs E, Cuervo LG, Lumbiganon P, et al. Improving the reporting of public health intervention research: advancing TREND and CONSORT. J Public Health (Oxf). 2008;30(1):103–9. doi:10.1093/pubmed/fdm082.
Prady SL, Richmond SJ, Morton VM, Macpherson H. A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLoS One. 2008;3(2), e1577. doi:10.1371/journal.pone.0001577.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
Moher D, Stewart L, Shekelle P. Implementing PRISMA-P: recommendations for prospective authors. Sys Rev. 2016;5(1):15. doi:10.1186/s13643-016-0191-y.
Altman DG, Moher D. Importance of transparent reporting of health research. In: Moher D, Altman DG, Schulz KF, Simera I, Wager E, editors. Guidelines for reporting health research: A user’s manual. Hoboken: Wiley; 2014. p. 3–13.
O'Neill O. Autonomy and trust in bioethics. Cambridge: Cambridge University Press; 2002.
Altman DG, Simera I. Using reporting guidelines effectively to ensure good reporting of health research. In: Moher D, Altman DG, Schulz KF, Simera I, Wager E, editors. Guidelines for reporting health research: A user’s manual. Hoboken: Wiley; 2014. p. 32–40.
Altman DG, Moher D. Declaration of transparency for each research article. BMJ. 2013;347:f4796. doi:10.1136/bmj.f4796.
Simera I, Altman DG, Moher D, Schulz KF, Hoey J. Guidelines for reporting health research: The EQUATOR network's survey of guideline developers. PLoS Med. 2008;5(6), e139. doi:10.1371/journal.pmed.0050139.t001.
SML is supported by a Clinician Scientist award from the National Institute for Health Research, EIB is supported by a New Investigator Award from the Canadian Institutes of Health Research, Canadian Association of Gastroenterology, and Crohn’s and Colitis Canada. DM is supported by a University (of Ottawa) Research Chair.
There are no competing financial interests to declare. DM is an editorial board member for BMC Medicine (Health Economics, Quality and Reporting). SN is an Associate Editor for BMC Medical Ethics (Ethics in Biomedical Research). Neither DM nor SN were involved in the editorial decision-making processes.
SN, EIB, SML and DM provided intellectual contribution to the manuscript. SN produced the first draft; EIB, SML and DM revised the manuscript. All authors reviewed and approved the final version of the manuscript.
SN is Clinical Investigator and Methodologist at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute, and Research Associate at the School of Epidemiology, Public Health and Preventive Medicine at the University of Ottawa. SN is a member of the Ontario Child Health SPOR Support Unit.
SML is Senior Lecturer at the London School of Hygiene and Tropical Medicine and honorary consultant dermatologist at St John’s Institute of Dermatology, London. She is co-chair of the REporting of studies Conducted using Observational Routinely collected Data (RECORD) steering committee and has co-led the development of its guidelines.
EIB is an Assistant Professor in the Department of Pediatrics and the School of Epidemiology, Public Health and Preventive Medicine at the University of Ottawa. He is also a physician in the Division of Gastroenterology, Hepatology and Nutrition at CHEO, a scientist at the CHEO Research Institute, and a scientist at the Institute for Clinical Evaluative Sciences. He is co-chair of the RECORD steering committee and helped develop its guidelines.
DM is a Senior Scientist with the Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Health Research Institute, an Associate Professor in the School of Epidemiology, Public Health and Preventive Medicine at the University of Ottawa, and holds a University Research Chair. He serves as Director of the Canadian Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Centre and helped develop many reporting guidelines including the CONSORT and PRISMA Statements.